SynthesisItalian journal of pediatrics2026
Therapeutic hypothermia in newborns: evidence-based guidelines from a systematic review.
Synthesis in Italian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neonatal Epilepsy: Beyond Seizures in a Developing Brain-A Narrative Review.Brain sciences · 2026Review
- Therapeutic Hypothermia in Sudden Unexpected Postnatal Collapse: Feasibility, Risks, and Long-Term Outcomes-A Systematic Review.Children (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypoxic-ischemic encephalopathy represents a major cause of neonatal mortality and long-term neurodevelopmental impairment. Therapeutic hypothermia has become the standard of care, significantly improving survival and outcomes. Nevertheless, its clinical implementation often lacks a standardized operational framework to ensure consistent efficacy and safety. The present work aimed to develop GRADE-based operational guidelines for therapeutic hypothermia, offering neonatologists a structured approach for identifying, treating, and monitoring newborns throughout the procedure. A panel of experts appointed by the Italian Society of Neonatology conducted a systematic review (PROSPERO registration CRD420250651303) of randomized controlled trials evaluating the effects of therapeutic hypothermia on neurodevelopmental outcomes. Literature searches were performed across Medline, Cochrane, Scopus, Embase, and Web of Knowledge databases, and studies were assessed using the Cochrane Risk-of-Bias 2 tool. Recommendations were formulated through consensus meetings following GRADE methodology and subsequently validated by an external multidisciplinary panel. Eight randomized controlled trials, encompassing a total of 1,843 newborns, met the inclusion criteria. Based on a comprehensive evaluation of study indications, characteristics, and outcomes, evidence-based recommendations were established. The risk-of-bias assessment revealed an even distribution between studies categorized as low and moderate risk. The resulting guidelines present a structured protocol covering all phases of therapeutic hypothermia - timing, clinical setting, management, and follow-up - and include proposals for expanding its application. To facilitate clinical implementation, the guidelines are accompanied by summary tables, graphical flowcharts, and algorithms designed for immediate use in neonatal intensive care settings. The GRADE-based recommendations presented here, now adopted as the Italian national clinical guidelines for therapeutic hypothermia in newborns, provide an evidence-driven and standardized framework to optimize neonatal care. These guidelines are intended to support daily clinical decision-making and will undergo periodic updates to incorporate emerging evidence and maintain their clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.